Odds of cardiovascular mortality 14.8% higher in black Americans with both conditions.
For patients taking metformin, TZD and DPP-4i linked to lower mortality, cardiovascular risks.
There was also a 22% reduction in the development of renal outcomes with liraglutide compared to placebo.
When taken in higher-than-recommended amounts, loperamide can cause cardiovascular conditions.
Coronary artery disease before transplantation increases death risk by 77%, study finds.
Patients exposed to high levels of air pollution have an elevated risk of cardiovascular disease.
The researchers found no relationship between poor quality of life and CKD progression.
The FDA has developed 2- and 10-year goals to reduce sodium content in both processed and prepared foods.
Increased risk for cardiovascular events and all-cause mortality for patients with type 2 diabetes.
Renal function decline is independent factor for cardiovascular risk in patients with type 2 diabetes.
One in 4 MI survivors develop heart failure within 4 years.
Cardiovascular disease risk is elevated when low HDL-C was accompanied by LDL-C and triglycerides.
CKD patients with daily sodium above 4,548 mg may help protect their cardiovascular health by reducing sodium in their diets, researchers suggested.
Odds of non-fatal stroke are 49% higher in patients in the fourth quartile of uric acid level versus those in the second quartile.
The findings warrant reconsideration of blood pressure targets for many patients older than 75, according to an editorial.
45% of all myocardial infarctions studied were silent MIs.
Researchers say restricting sodium might backfire, but heart experts are critical of the finding.
Researchers find risk is reduced by as much as 80%.
Odds increase with rapid rise in middle age.
Latest findings from national trial show it lowers chances of heart failure, even in older adults.
Updated review and meta-analysis show beneficial effect for CABG for long-term mortality.
The number of CAC vessels allowed researchers to correctly estimate the likelihood of both coronary heart disease and cardiovascular disease.
Findings among patients on chronic antiplatelet therapy for cardioprotection.
LDL-C and triglyceride reductions depend on choice and dose of statin prescribed.
Preventing cardiovascular disease through adherence to Life's Simple 7 can also prevent the development of CKD.
In-hospital mortality risk was more than double among patients whose hyperkalemia persisted than those whose potassium levels normalized.
Treatment with angiotensin-converting enzyme inhibitors was most strongly associated with hyperkalemia.
Researchers found no significant differences in instances of CVD in patients treated with GLP-1RA compared to DPP-4i in combination with metformin.
Female gender and more severe angina based on Canadian Cardiovascular Society class were considered predictors of depression.
Evacetrapib did lower low-density lipoprotein cholesterol in high vascular risk patients, but did not reduce major cardiovascular events.
- Blacks With Diabetes and CKD Have Higher CVD Risk
- Worse Re-transplant Outcomes for HIV Positive Patients
- Race, Procedure Type Influence Morbidity in Pediatric Surgery Patients
- Parathyroidectomy Rates Stable Despite Changes in Medical Therapy
- Early Recurrence After Laparoscopic Radical Cystectomy Explored
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)